Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare Drug Reimbursement Fix To Be Added To House Spending Bill

Executive Summary

Legislation to reform Medicare's drug reimbursement system will be added to a spending bill in October, House Commerce/Oversight & Investigations Subcommittee Chairman Jim Greenwood (R-Penn.) said Sept. 21.

You may also be interested in...



AWP Changes’ Impact On Long-Term Care Pharmacy Is Focus For Assoc.

The Long Term Care Pharmacy Alliance Executive Director Stephen Northrup will focus on assuring reimbursement for pharmacist services within the context of potential revisions to Medicare's average wholesale price system

AWP Changes’ Impact On Long-Term Care Pharmacy Is Focus For Assoc.

The Long Term Care Pharmacy Alliance Executive Director Stephen Northrup will focus on assuring reimbursement for pharmacist services within the context of potential revisions to Medicare's average wholesale price system

Medicaid Rx Price Data Could Be Used For Medicare Payments - HHS IG

The "Average Manufacturer Price" used as the basis for rebate calculations in Medicaid is the best alternative to AWP for reforming the Medicare prescription drug reimbursement methodology, HHS Deputy Inspector General George Grob suggested during a Sept. 21 hearing.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS038543

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel